We narrowed to 5,790 results for: SPI

#229819

A gateway compatible Tol2 destination vector containing the fli1a promoter driving Cre and TagBFP in endothelial cells followed by 2 cHS4 insulator cores.

Joshua Wythe

Gillespie WB et al Development. 2025 Nov 15;152(22):dev2043

Feb. 26, 2025

Academic Institutions and Nonprofits only

#229820

An AAV, tet-off, gateway-compatible destination vector with cre-dependent expression of the insert. EFS driving destablized rTA

Joshua Wythe

Gillespie WB et al Development. 2025 Nov 15;152(22):dev2043

Feb. 26, 2025

Academic Institutions and Nonprofits only

#229823

A CAGGS driven luciferase reporter followed by a P2A cleavage peptide and an H2A mCherry cassette for nuclear labeling.

Joshua Wythe

Gillespie WB et al Development. 2025 Nov 15;152(22):dev2043

Feb. 26, 2025

Academic Institutions and Nonprofits only

#229831

A gateway compatible Tol2 destination vector containing the hsp70 promoter driving Cre and TagBFP in endothelial cells followed by 2 cHS4 insulator cores.

Joshua Wythe

Gillespie WB et al Development. 2025 Nov 15;152(22):dev2043

Feb. 13, 2025

Academic Institutions and Nonprofits only

#229838

A Tol2 based expression vector for RU486 inducible expression of GFP in the nucleus with a destablized lex transactivator.

Joshua Wythe

Gillespie WB et al Development. 2025 Nov 15;152(22):dev2043

Feb. 13, 2025

Academic Institutions and Nonprofits only

#226456

Mammalian expression of S protein of SARS-CoV2 under CMV promoter, tagged with 6His and released extracellular environment after expression for protein purification

Urartu Seker

Ozcelik et al ACS Pharmacol Transl Sci. 2024 Mar 21;7(

Jan. 16, 2025

Academic Institutions and Nonprofits only

#224474

Gateway compatible 5' entry clone with human alpha 2 globin pause site (to prevent transcription readthrough) and EF1a core promoter. Lacks downstream intron for a lower-activity, compact promoter.

Joshua Wythe

Gillespie WB et al Development. 2025 Nov 15;152(22):dev2043

Sept. 30, 2024

Academic Institutions and Nonprofits only

#224505

Gateway compatible middle entry clone containing a Destablized LexA and LexOperon with minimal CaMV 35S promoter as an all in one casette for RU486 driven gene expression

Joshua Wythe

Gillespie WB et al Development. 2025 Nov 15;152(22):dev2043

Sept. 27, 2024

Academic Institutions and Nonprofits only

#224506

Gateway compatible middle entry clone containing a Destablized LexA and LexOperon with 3' minimal c-Fos promoter for an all in one RU486 driven gene expression construct

Joshua Wythe

Gillespie WB et al Development. 2025 Nov 15;152(22):dev2043

Sept. 27, 2024

Academic Institutions and Nonprofits only

#224512

A Gateway compatible middle entry clone containing Biotin Ligase followed by T2A and mCherry membrane reporter (biotinylation and flourescent cell membrane reporter)

Joshua Wythe

Gillespie WB et al Development. 2025 Nov 15;152(22):dev2043

Sept. 26, 2024

Academic Institutions and Nonprofits only